Notes on DSM-5 and DSM-5-TR: History, Revision Processes, Structure, and Key Concepts

Brief History of DSM Editions
  • DSM-I (1952): First manual with a glossary; used “reaction” for disorders.

  • DSM-II: Based on ICD-8, both effective in 1968.

  • DSM-III (1980): Introduced explicit diagnostic criteria, theory-neutral approach; coordinated with ICD-9.

  • DSM-III-R (1987): Revisions and corrections to DSM-III.

  • DSM-IV (1994): Culmination of a 6-year effort with extensive review; coordinated with ICD-10 (published 1992).

DSM-5 Revision Process (Overview)
  • Initiated in 1999 to evaluate DSM strengths/weaknesses; coordinated with WHO, WPA, NIMH.

  • Involved 13 international research planning conferences (2003–2008) shaping DSM-5 and ICD-11 revisions.

  • Led by David J. Kupfer, M.D., and Darrel A. Regier, M.D., M.P.H. (2006); involved a Task Force and >130 work group members.

  • Aimed for an evolutionary stage in classification, building on DSM-IV and setting strategic directions.

DSM-5 Revision Process (Continued)
  • Iterative 6-year effort including literature reviews, drafting criteria, public posting, field trials, and revisions.

  • Involved broad stakeholders: clinicians, individuals with lived experience, families, lawyers, advocacy groups.

  • Guiding principles:
    1) Feasible for routine clinical use.
    2) Guided by research evidence.
    3) Continuity with previous editions where possible.
    4) Avoid arbitrary changes between DSM-IV and DSM-5.

  • Focus areas included diagnostic issues, methodological concerns, and cross-cutting issues.

  • Decision criteria: public health, clinical utility, evidence strength, reliability/validity, benefits/risks.

DSM-5 Field Trials and Empirical Validation
  • Introduced reliability validation (inspired by DSM-III).

  • Two field-trial designs:

    • Medical-academic settings: Large, diverse sites; tested reliability and clinical utility of major revisions using stratified samples and blinded clinicians; utilized cross-cutting symptom inventories.

    • Routine clinical practice: Recruited generalist and specialty clinicians to assess feasibility and utility in everyday practice.

  • Outcome observation assessed reliability (κ) and utility; anticipated future work on validity.

  • Key metrics included reliability (κ, ICC) and prevalence data.

  • Formulas:

    • Cohen’s kappa: κ=p<em>op</em>e1pe\kappa = \frac{p<em>o - p</em>e}{1 - p*e}

    • Intraclass Correlation Coefficient (ICC): ICC=MS<em>BMS</em>WMS<em>B+(k1)MS</em>WICC = \frac{MS<em>B - MS</em>W}{MS<em>B + (k-1)MS</em>W}

Public and Professional Review (DSM-5)
  • DSM-5 revision website (www.dsm5.org) launched in 2010 for public/professional input.

  • Multiple comment periods (2010, 2011, 2012) resulted in >13,000 signed comments and influenced revisions.

  • Ensured clinical utility remained a priority and addressed concerns of users and advocacy groups.

Expert Review, Forensic Review, and Final Approval
  • Expert work groups, Scientific Review Committee (SRC), and Clinical and Public Health Committee (CPHC) reviewed proposals.

  • SRC used data-driven judgments; CPHC reviewed clinical utility and public health implications, including forensic input.

  • Final approval by APA Assembly and Board of Trustees in December 2012.

Revisions to DSM-5: Iterative Revision Process (DSM-5-TR and beyond)
  • DSM-5 Iterative Revision (2014–): Enabled ongoing updates via digital publishing; continuous proposals reviewed by five standing Review Committees.

  • DSM-5-TR development (Spring 2019): >200 experts conducted 10-year literature reviews; involved disorder review groups and cross-cutting groups (Culture, Sex and Gender, Suicide, Forensic, Ethnoracial Equity and Inclusion).

  • Text revision scope: Clarified existing criteria without introducing conceptual changes; reviewed and approved by DSM Steering Committee, APA Assembly, and Board of Trustees.

Changes in DSM-5 Organizational Structure and Utility
  • Goals: Improve clinical utility, harmonize with ICD, align with research on cross-cutting factors.

  • Disorders are grouped into spectra based on 11 indicators (e.g., neural substrates, genetic risk, symptom similarity).

  • Aligned organizational structure with ICD-11 where possible; U.S. coding remains ICD-10-CM.

  • Disorders organized by developmental/lifespan trajectories.

  • Emphasizes a predominantly categorical approach with dimensional elements for subthreshold features.

Harmonization with ICD-11 and Global Standards
  • Aimed to harmonize DSM and ICD for better health statistics and research.

  • DSM-5 development outpaced ICD-11, limiting full criteria harmonization.

  • ICD-11 endorsed by WHO in May 2019, effective January 1, 2022; U.S. uses ICD-10-CM.

Key Conceptual Frameworks and Approaches
  • Definition of a Mental Disorder: Clinically significant disturbance in cognition, emotion, or behavior reflecting dysfunction, causing distress or disability; excludes expectable responses to stress/loss and social deviance alone.

  • Forensic Use: Requires additional information beyond DSM-5 for legal judgments.

  • Categorical vs Dimensional Diagnoses: DSM-5-TR maintains categorical classifications with dimensional elements for nuanced information and research.

  • Cross-Cutting Symptom Measures: Level 1 Measure (Section III) assesses major psychiatric domains for latent disorders and sub-syndromal conditions; recommended for initial evaluation and monitoring.

DSM-IV Multiaxial System: Removal in DSM-5
  • DSM-IV Axes I–IV–V were removed.

  • Nonaxial documentation lists disorders by clinical importance, with psychosocial/contextual factors (formerly Axis IV) now as Z codes.

  • WHODAS (from ICF) replaced the GAF scale in Section III for global functional assessment.

Cultural, Race, and Social Context in DSM-5-TR
  • Mental disorders are recognized within sociocultural norms; context shapes symptom expression, prevalence, and stressors.

  • Cultural Concepts of Distress replaced culture-bound syndromes:
    1) Cultural idiom of distress: Language/terms for distress.
    2) Cultural explanation or perceived cause: Culturally coherent etiologies.
    3) Cultural syndrome: Cluster of symptoms in a specific cultural group.

  • Racism and Discrimination: Recognized as social determinants of health influencing mental health, diagnosis, and treatment; clinicians should address bias.

  • DSM-5-TR updates: Dedicated review committees; updated language (e.g., “racialized,” “ethnoracial”); avoidance of “Caucasian”; use of non-stigmatizing language; contextualized prevalence data.

Sex and Gender Considerations
  • Clarified distinctions between sex (biological) and gender (identity/role).

  • Sex/gender influences disorder risk, prevalence, symptom expression, and treatment, including reproductive life-cycle events.

  • Specifiers (e.g., “with peripartum onset”) reflect these factors.

Association With Suicidal Thoughts or Behavior
  • New text section for each diagnosis details associations with suicidal thoughts or behavior.

  • Clinicians must use individual risk factors and clinical judgment for suicide risk assessment, not diagnosis alone.

Conditions for Further Study; Assessment Tools; and Future Directions
  • Section III contains Conditions for Further Study for ongoing research.

  • Assessment and Monitoring Tools (e.g., Level 1 Cross-Cutting Symptom Measure) establish baselines and monitor changes over time.

Use of the DSM-5-TR: Practical Application
  • Primary purpose: Assist clinicians in diagnosing and informing treatment plans.

  • Case formulation integrates clinical history and social/psychological/biological context; criteria are guidelines.

  • Avoid rigid application; flexibility and clinical judgment are crucial.

  • Diagnostic criteria sections (e.g., prevalence, development, risk factors) support informed decision-making.

Elements of a Diagnosis; Subtypes, Specifiers, and ICD Coding
  • Subtypes: Mutually exclusive phenomenological subgroups (e.g., anorexia nervosa, restricting type).

  • Specifiers: Additional features, non-exclusive, used with subtypes (e.g., MDD with mixed features).

  • ICD-10-CM Codes: Most disorders include corresponding codes; some subtypes/specifiers are documented as post-nomenclature descriptors.

  • Alternative presentations:

    • Other Specified Disorder: Specify reason criteria not met.

    • Unspecified Disorder: Used when reason cannot or is not specified (e.g., emergency settings).

Clinical Judgment, Diagnostic Significance, and Recording Procedures
  • DSM-5 designed for clinical, educational, and research use; requires trained diagnosis and clinical judgment.

  • Diagnostic Significance Criterion: Distress/impairment establishes disorder thresholds where biological markers are absent.

  • Recording and Coding: U.S. uses ICD-10-CM; principal diagnosis is main reason for admission/visit.

  • Provisional Diagnosis: Used when information is incomplete but presumption exists, or duration criteria are uncertain.

Terminology and Conceptual Refinements
  • Substance/Medication-Induced Mental Disorder: Emphasizes substances/medications causing symptoms, including withdrawal.

  • Independent Mental Disorders: Replaces older “organic/nonorganic”/“primary” terms.

  • Other Medical Conditions: Emphasizes mental disorders can be precipitated by medical conditions, avoiding mind-body dualism.

Types of Information in the DSM-5-TR Text
  • Text sections include: Recording Procedures, Subtypes, Specifiers, Diagnostic Features, Associated Features, Prevalence, Development and Course, Risk and Prognostic Factors, Culture-Related Diagnostic Issues, Sex- and Gender-Related Diagnostic Issues, Diagnostic Markers, Association With Suicidal Thoughts or Behavior, Functional Consequences, Differential Diagnosis, Comorbidity.

Other Conditions in Section II
  • Includes chapters for non-mental-disorder conditions: Medication-Induced Disorders and Other Adverse Effects of Medication, and Other Conditions That May Be a Focus of Clinical Attention (e.g., psychosocial stressors).

Practical Takeaways for Exam Preparation
  • DSM-5-TR: Predominantly categorical with dimensional components.

  • Evolution: Increased empirical grounding, international collaboration, clinical utility, suicidality caution, sociocultural attention.

  • Structure: Life-span development, cross-cutting measures, ICD-11 alignment (with ICD-10-CM for U.S. coding).

  • Key terminologies for exams: Level 1 Cross-Cutting Symptom Measure, Subtypes vs Specifiers, Other Specified vs Unspecified, Provisional diagnoses, Nonaxial documentation, Cultural concepts of distress, Risk factors, validators.

  • Important online resources: DSM history (psychiatry.org), DSM-5/DSM-5-TR updates (dsm5.org), DSM-5-TR text (psychiatryonline.org).

  • Equations: Cohen's kappa, Intraclass Correlation Coefficient (ICC).